Valeant Pharma (VRX) Misses Dramatically Reduced Expectations - BMO

Go back to Valeant Pharma (VRX) Misses Dramatically Reduced Expectations - BMO

Form 8-K Valeant Pharmaceuticals For: Mar 15

March 15, 2016 6:16 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More